| Primary |
| Drug Use For Unknown Indication |
33.3% |
| Parkinson's Disease |
33.3% |
| Reflux Gastritis |
33.3% |
|
| Drug Interaction |
50.0% |
| Liver Disorder |
50.0% |
|
| Secondary |
| Parkinson's Disease |
59.6% |
| Drug Use For Unknown Indication |
7.3% |
| Product Used For Unknown Indication |
6.0% |
| Hypertension |
3.6% |
| Pain |
3.6% |
| Asthma |
2.8% |
| Parkinsonism |
2.3% |
| Drug Effect Decreased |
2.0% |
| Cerebrovascular Accident |
1.6% |
| Dementia |
1.5% |
| Dementia With Lewy Bodies |
1.3% |
| Antidepressant Therapy |
1.2% |
| Anxiety |
1.2% |
| Depression |
1.1% |
| Restless Legs Syndrome |
1.1% |
| Psychotic Disorder |
0.9% |
| Benign Prostatic Hyperplasia |
0.8% |
| Cardiac Failure |
0.8% |
| Insomnia |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
|
| Pathological Gambling |
17.3% |
| Abnormal Behaviour |
6.9% |
| Lethargy |
6.4% |
| Pyrexia |
5.8% |
| Thrombocytopenia |
5.8% |
| Sopor |
5.2% |
| Syncope |
5.2% |
| Tremor |
5.2% |
| Death |
4.0% |
| Hallucination |
4.0% |
| Liver Disorder |
4.0% |
| Suicide Attempt |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Completed Suicide |
3.5% |
| Sudden Onset Of Sleep |
3.5% |
| Theft |
3.5% |
| Drug Interaction |
2.9% |
| Hallucination, Visual |
2.9% |
| Mental Disorder |
2.9% |
| Nausea |
2.9% |
|
| Concomitant |
| Parkinson's Disease |
40.8% |
| Product Used For Unknown Indication |
12.6% |
| Drug Use For Unknown Indication |
12.5% |
| Hypertension |
8.6% |
| Pain |
2.7% |
| Constipation |
2.7% |
| Depression |
2.7% |
| Restless Legs Syndrome |
2.2% |
| Osteoporosis |
1.7% |
| Parkinsonism |
1.7% |
| Diabetes Mellitus |
1.7% |
| Renal Failure |
1.7% |
| Hallucination |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Atrial Fibrillation |
1.2% |
| Dementia |
1.1% |
| Insomnia |
1.0% |
| Drug Effect Decreased |
0.9% |
| Asthma |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
|
| Vomiting |
10.7% |
| Parkinson's Disease |
8.2% |
| Tremor |
7.1% |
| Malaise |
5.8% |
| Pneumonia |
5.8% |
| Hypoglycaemia |
5.2% |
| Loss Of Consciousness |
5.2% |
| Progressive Multifocal Leukoencephalopathy |
4.9% |
| Somnolence |
4.7% |
| Atrial Fibrillation |
4.4% |
| Sudden Onset Of Sleep |
4.4% |
| General Physical Health Deterioration |
4.1% |
| Hallucination |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Death |
3.8% |
| Pyrexia |
3.6% |
| Sepsis |
3.6% |
| Vitreous Floaters |
3.6% |
| Sopor |
3.3% |
| Urinary Tract Infection |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
29.7% |
| Parkinson's Disease |
25.7% |
| Epilepsy |
8.0% |
| Anaesthesia |
4.6% |
| Restless Legs Syndrome |
4.0% |
| Hypertension |
3.4% |
| Depression |
2.9% |
| Diuretic Therapy |
2.3% |
| Gastritis Erosive |
2.3% |
| Pain |
2.3% |
| Thyroid Disorder |
2.3% |
| Urinary Tract Infection |
2.3% |
| Osteoporosis |
1.7% |
| Reflux Gastritis |
1.7% |
| Cardiac Failure |
1.1% |
| Dyslipidaemia |
1.1% |
| Muscle Spasms |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Secondary Hyperthyroidism |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
|
| Drug Interaction |
20.6% |
| Hallucination |
11.8% |
| Serotonin Syndrome |
8.8% |
| Gastrointestinal Haemorrhage |
5.9% |
| Reflux Gastritis |
5.9% |
| Transaminases Increased |
5.9% |
| Tremor |
5.9% |
| Depressed Level Of Consciousness |
2.9% |
| Disorientation |
2.9% |
| Fall |
2.9% |
| Hallucination, Visual |
2.9% |
| Headache |
2.9% |
| Incorrect Drug Administration Rate |
2.9% |
| Infectious Peritonitis |
2.9% |
| Insomnia |
2.9% |
| Peritonitis |
2.9% |
| Restlessness |
2.9% |
| Weight Decreased |
2.9% |
| Wrong Drug Administered |
2.9% |
|
